Krenzien, Felix
Schmelzle, Moritz
Pratschke, Johann
Syn, Nicholas L.
Sucandy, Iswanto
Chiow, Adrian K. H.
Marino, Marco V.
Gastaca, Mikel
Wang, Xiaoying
Lee, Jae Hoon
Chong, Charing C.
Fuks, David
Choi, Gi Hong
Efanov, Mikhail
Kingham, T. Peter
D’Hondt, Mathieu
Troisi, Roberto I.
Choi, Sung Hoon
Sutcliffe, Robert P.
Liu, Rong
Cheung, Tan-To
Tang, Chung Ngai
Han, Ho-Seong
Goh, Brian K. P. http://orcid.org/0000-0001-8218-4576
Chan, Chung-Yip
D’Silva, Mizelle
Schotte, Henri
De Meyere, Celine
Lai, Eric C. H.
Kadam, Prashant
Montalti, Roberto
Liu, Qu
Lee, Kit Fai
Salimgereeva, Diana
Alikhanov, Ruslan
Lee, Lip Seng
Prieto, Mikel
Jang, Jae Young
,
Funding for this research was provided by:
US National Cancer Institute MSKCC Core Grant (P30 CA008747)
Article History
Received: 23 May 2022
Accepted: 12 March 2023
First Online: 12 April 2023
Declarations
:
: (i) Dr Brian Goh has received travel grants and honorarium from Johnson and Johnson and Transmedic the local distributor for the Da Vinci Robot. (ii) Dr Marco Marino is a consultant for CAVA robotics LLC. (iii) Johann Pratschke reports a research grant from Intuitive Surgical Deutschland GmbH and personal fees or non-financial support from Johnson & Johnson, Medtronic, AFS Medical, Astellas, CHG Meridian, Chiesi, Falk Foundation, La Fource Group, Merck, Neovii, NOGGO, pharma-consult Peterson, and Promedicis. (iv) Moritz Schmelzle reports personal fees or other support outside of the submitted work from Merck, Bayer, ERBE, Amgen, Johnson & Johnson, Takeda, Olympus, Medtronic, Intuitive. (v) Drs Felix Krenzien, Nicholas Syn, Iswanto Sucandy, Adrian Chiow, Mikel Gastaca, Xiaoying Wang, Jae Hoon Lee, Charing Chong, David Fuks, Gi-Hong Choi, Mikhail Efanov, Peter Kingham, Mathieu D’Hondt, Roberto Troisi, Sung-Hoon Choi, Robert Sutcliffe, Rong Liu, Cheung Tan To, Chung Ngai Tang and Ho Seong Han have no conflicts of interest to declare.